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In predictive DNA testing for hereditary cancer, test results should
traditionally be disclosed face-to-face. Increasingly, however, counselees
ask to receive their test result at home by letter. To compare the quality of
genetic counselling in the traditional way to a procedure in which
counselees are offered a choice on how to get their test result. Counselees
from families with a known BRCA1/2 or Lynch syndrome mutation were
randomised into two groups. The control group was given the DNA test
result in a face-to-face consultation. In the intervention group people could
choose to learn their test result face-to-face or by letter. The quality of
genetic counselling was assessed through questionnaires at three different
moments. Data of 198 counselees were analysed. The quality of genetic
counselling and psychological functioning were equally good in both
groups. The majority of cases chose for disclosure by letter. The
counselees with a good test result in the intervention group were the most
satisfied. Our results indicate that in predictive DNA testing for BRCA1/2
and Lynch syndrome, a choice protocol is equally safe and more
satisfying. Moreover, it is more efficient for both counsellor and counselee.
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Presymptomatic DNA testing is embedded in genetic
counselling and is usually offered by clinical genetics
departments in university hospitals. On the basis of the
Huntington’s disease protocol, this type of DNA test-
ing in the Netherlands traditionally requires at least two
counselling sessions, including face-to-face disclosure
of the test results (1). However, there is an increas-
ing demand from our patients for more freedom of
choice within the procedure. Specifically, a substantial
group of patients wants to learn their DNA result by
letter, followed by an optional extensive counselling
session if a mutation is found. They argue that they
would prefer to deal with the first emotions after dis-
closure of the DNA result in a private setting and
have a counselling appointment several days later. They
also indicate that having to travel long distances and




The traditional counselling model for pre-
symptomatic DNA testing, including face-to-face dis-
closure of the result, was developed for Huntington’s
disease, an untreatable degenerative neurological disor-
der (2). Strictly following this counselling model might
unnecessarily restrict the freedom of choice for patients
tested for syndromes that are, to some extent, treatable
and preventable, e.g. BRCA1 and BRCA2 associated
hereditary breast-ovarian cancer and Lynch syndrome
hereditary colorectal cancer (3). A less strict protocol
may be defendable because it has been well docu-
mented that the psychological impact of DNA testing in
these disorders is limited (4–11). As patient autonomy
is increasingly one of the corner stones of good clinical
practice, limiting a patient’s choice on how to be given
the DNA result must be based on evidence. We there-
fore decided to investigate whether disclosing a DNA
result by letter instead of face-to-face had any effect
in terms of psychological harm and, more generally, in
terms of the quality of genetic counselling and patient
satisfaction. Although an alternative approach of coun-
selling by phone has been investigated in hereditary
cancer (12–14), no studies on disclosing the result by
letter have been published so far. The results for coun-
selling by phone turned out to be positive. Counselees
were more satisfied when they got the choice between
disclosure by phone or in a face-to-face consultation,
than if the result was only given face-to-face (12).
Disclosure by phone did not negatively affect their
knowledge about the disease, psychological function-
ing or satisfaction. Anxiety was not higher after hear-
ing the result by phone (13). When offered a choice,
counselees chose disclosure by phone more often than
face-to-face (13, 14). Disclosure by phone was cheaper
because it took less travel- and consultation time for
both counsellor and counselee.
Here, we report on the quality of counselling for
patients at risk of having a familial mutation in
BRCA1, BRCA2 or one of the Lynch syndrome genes;
we compared the traditional procedure with one that
provides a choice of how the test result was disclosed
(by letter or face-to-face).
The quality of the genetic counselling was assessed
by measuring the counselees’ knowledge about the
disease, decision-making processes, risk perception,
personal control, psychological functioning and satis-
faction. For these six quality aspects there have been
formulated two hypotheses:
(1) Between both variants of the result disclosure proto-
cols there will be no difference in the first five men-
tioned quality aspects of the genetic counselling;
the satisfaction about the result disclosure will be
greater in the choice variant.
(2) The result of the DNA test (favourable vs un-
favourable result) will have an influence on the
satisfaction: the satisfaction about the result disclo-
sure will be the lowest when there is a favourable




Participants were recruited between September 2007
and December 2010. All counselees referred to the clin-
ical genetics department at the University Medical Cen-
ter Groningen (UMCG) because a germline mutation in
the BRCA1 or BRCA2 gene or in one of the Lynch
syndrome-associated genes had been identified in their
family, were eligible. This means that counselees from
families with unexplained variants were not included.
Together with an invitation letter for the intake ses-
sion and the usual general information leaflets on the
procedure of genetic counselling and on family history
retrieval, the counselees were sent information about
our study with an informed consent form and a first
questionnaire. The rationale for the study, tailoring the
disclosure of DNA test results to the needs and wishes
of the counselees, was formulated in the invitation let-
ter. It was made clear that participation in this study
would in no way affect their eligibility for DNA testing
and counselling. Participants who agreed to participate
knew they had to complete questionnaires at three time
points: before the intake (T1), 2–3 days after receiv-
ing the DNA result (T2), and 4–6 weeks later (T3).
There was a period of 2–6 weeks between the invi-
tation and intake session, and 5–7 weeks between the
intake and result of the DNA test. Counselees who had
not returned an informed consent form 2 weeks before
the intake were reminded by phone that they could take
part in the study. The study was approved by the UMCG
institutional board.
Study population
Almost all the participants had a 50% chance of having
a familial BRCA1/2 or Lynch syndrome mutation. For
the inclusion into our study, participants had to be
pre-symptomatic (no cancer in the past) and speak
sufficient Dutch. The Lynch syndrome group consisted
of both men and women of 18 years and older, while the
BRCA1/2 group consisted of women aged 25 and older,
because the younger women were already participating
in another study. The exclusion criteria are mentioned
in the flow chart (Figure 1).
Of 346 counselees who were invited to participate,
246 returned questionnaire T1 (71.1%). The best way
to test our hypotheses is running a randomized con-
trolled trial, where all the counselees are randomly
assigned into either the traditional or choice group. In
the traditional protocol, an appointment for a face-to-
face session is planned when the DNA test result is
available. Those in the choice protocol were informed
about the pros and cons of either option (i.e. result
disclosed face-to-face or disclosure by letter with a sub-
sequent face-to-face appointment with a genetic coun-
sellor within 1 week) in a standardised way during the
intake. Those who chose for disclosure at the depart-
ment got an appointment when the DNA test result
was available. Those who opted for disclosure by letter,
received a concise letter containing the DNA test result
422
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Participants (n=346) who were
ascertained
Drop-outs (n=100)
- declined by letter (n=42)
- no response (n=58)
Participants (n=246) who
returned the first questionnaire
(T=1)
Participants (n=165)
who returned a second





male BRCA counselees (n=4), no known familial
mutation (n=9), no indication for DNA testing
(n=3), refrained from DNA test (n=16), breast
cancer in the past (n=4), psychological contra-
indication (n=1), no questionnaire sent (n=3),
exceeded study time (n=8)
Drop-outs (n=33)




















Fig. 1. Flow chart of the study design.
as well as an appointment within 1 week to discuss
the results face-to-face. In this letter, it was formulated
that they could contact us to cancel the planned face-
to-face appointment if they wished to, in which case
they would get a second letter with a more extensive
conclusion, written in such a way that it would also be
comprehensible for their general practitioner (GP) and
their children. This conclusive letter to the counselee
is standard care in genetic counselling in the Nether-
lands. The disclosure letter was written and signed by
their ‘own’ genetic counsellor or clinical geneticist and
included their phone number to give immediate access
if needed. In total, 165 counselees returned question-
naire T2 (47.7%). Because the traditional and choice
protocol were compared at each measuring point sep-
arately (T1, T2 and T3), counselees could be included
if they only returned the first and second question-
naires (24 counselees) or only the first and third ques-
tionnaires (14 counselees). One hundred twenty-seven
counselees returned all three questionnaires. After T1,
48 counselees were excluded at the intake session and
we had 33 drop-outs occurred during the course of the
study (Figure 1). At T1, sociodemographic data were
obtained on gender, age, marital status, number of chil-
dren and education level.
Assessing the quality of genetic counselling
Personal control
The perceived personal control (PPC) questionnaire
assesses how much personal control people experience
as a counselee and is a valid measure for the evaluation
of genetic counselling outcomes (15, 16). All nine items
were counted and used as an indicator of personal con-
trol. The internal consistency was high in this sample
[Cronbach’s α of 0.82 (T1), 0.85 (T2) and 0.85 (T3)].
Knowledge, risk perception and decision-making
These questionnaires were based on those developed for
the breast cancer risk communication (BRISC) study,
a study of risk perception in hereditary cancer coun-
selling using different risk format ways (17). For the
knowledge questionnaire, participants needed to answer
eight statements on hereditary cancer and three ques-
tions about risk percentages for ‘cancer in general’, ‘a
predisposition to hereditary cancer’ and ‘getting can-
cer when having a predisposition to hereditary cancer’.
The total score could range from 0 to 11. A higher score
indicates more knowledge about hereditary cancer. The
internal consistency was moderate in this sample (Cron-
bach’s α of 0.65, 0.60 and 0.61).
The risk perception questionnaire had seven items.
Participants had to state how risky they found the per-
centages mentioned, to estimate their own chance of
getting cancer, and the anxiety they experienced about
it on a seven-point scale. The total score could range
from 0 to 49. A higher score indicates a higher risk per-
ception. The internal consistency was good (Cronbach’s
α of 0.85, 0.86 and 0.85).
For the decision-making questionnaire, participants
had to indicate how far they would be willing to follow
423
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Table 1. Questions on satisfaction with the counselling process in general (1–6, 9–10) and the procedure for disclosing the DNA
result (7–8)
1. How far have your expectations and/or needs been met?
2. How actively were you involved in the procedure (e.g. could you ask the questions you wanted to ask)?
3. How satisfied are you with the information you received during the procedure?
4. How satisfied are you with the practical and emotional support you received during the procedure?
5. Do you feel the counsellor had enough time for you?
6. How satisfied are you, in total, about the procedure?
7. How satisfied are you about the way in which the result of the DNA test was disclosed to you?
8. How high would you score the way you received the result?
9. How satisfied are you with the written report?
10. How satisfied are you about the reception at the department and the way you were treated?
different kinds of procedures (periodic screening, pro-
phylactic surgery and informing their family) if they
should receive an unfavourable DNA result. Answers
were given on a five-point scale ranging from ‘definitely
not’ to ‘definitely yes’.
Psychological functioning
Emotional problems were measured with the 12-item
version of the general health questionnaire (GHQ-
12) (18). The total score ranged from 0 to 12. A GHQ
score of 2 or higher indicates emotional problems.
The internal consistency was good (Cronbach’s α of
0.89, 0.90 and 0.90). Concerns about getting cancer
were measured with four items on the cancer worry
scale (CWS) (19, 20). This scale includes questions
on worries about getting cancer, influence on mood,
restrictions in daily activities, and worries about the
occurrence of cancer by family members on 4-point
scales ranging from ‘almost never’ to ‘almost always’.
The total score could range from 0 to 4. A higher score
indicates more worries about getting cancer. The inter-
nal consistency of the CWS in our study population was
low (Cronbach’s α of 0.58, 0.50 and 0.53), which means
that the results have to be interpreted with caution.
Satisfaction
This questionnaire was derived from the QUOTE-
geneca (Quality of care through the patient’s eyes)
scale (21). It assesses counselees’ opinion on the quality
and satisfaction of the counselling procedure. Eight
items were used and supplemented with two specific
items about the procedure for disclosing the test result
(questions 7 and 8; see Table 1). Participants could
indicate their satisfaction on visual analogue scales
between 0 and 10. A higher score indicates more
satisfaction. The items for ‘general satisfaction’ and
‘disclosure satisfaction’ were analysed separately. The
internal consistency was good for general satisfaction
[Cronbach’s α of 0.92 (T2) and 0.90 (T3)] and moderate
to good for disclosure satisfaction [Cronbach’s α of 0.78
and 0.68, respectively).
Statistical analyses
First, we compared the pre-test (T1) scores in the choice
group to the traditional group for the demographic and
dependent variables. Second, we checked differences
for the same variables between the participants and the
drop-outs. We used the chi-square test for the demo-
graphic data and the independent t-test for age and the
dependent variables. The groups were compared at T2
and T3, with the disclosure protocol (choice protocol
vs traditional protocol) and the DNA result (favourable
vs unfavourable) as independent variables. An anova




For the pre-test measurements, we excluded the
data from 48 participants, as these participants were
excluded later in the study and differ from our final
study sample (Figure 1). Thus, 198 cases were included
at T1, 99 in the traditional protocol group and 99 in the
choice group. Participants in the choice group were sig-
nificantly older than the participants in the traditional
group (M = 47.08, SD = 13.55 vs M = 42.09, SD =
13.34, t (142) = −2.58, p < 0.05), and they more often
had children (86.9 vs 69.7%, χ2 (1) = 8.59, p < 0.05).
In the traditional group, there were significantly more
Lynch syndrome counselees than in the choice group
(23.2 vs 11.1%, χ2(1) = 5.11, p < 0.05), see Table 2.
No significant differences were found between the
traditional and choice groups for dependent variables at
T1 (Table 2), so no corrections for pre-test differences
in further analyses were necessary. The number of
Lynch cases and the number of male cases was too
small to perform separate subgroup analyses.
Drop-outs
We found no significant differences between the 165
participants who had returned two or more question-
naires and the 33 drop-outs in the demographic and
dependent variables at T1. The number of drop-outs in
the two groups did not differ significantly: 17 in the
traditional group and 16 in the choice group.
The quality of genetic counselling
The disclosure procedure had no influence on coun-
selees’ knowledge about the disease, decision-making,
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Table 2. Demographic and dependent variables at T1
Traditional protocol (N = 99) Choice protocol (N = 99)
% n % n p
Demographic data
Agea,b
Mean (SD) 42.09 (13.34) 96 47.08 (13.55) 98 0.01∗
Gender
Women 93.9 93 92.9 92 1.00
Men 6.1 6 7.1 7
Marital status
Married 62.6 62 72.7 72 0.17
Unmarried 18.2 18 17.2 17
Living together 19.2 19 10.1 10
Children
Yes 69.7 69 86.9 86 0.01∗
No 30.3 30 13.1 13
Cancer type
BRCA1/2 76.8 76 88.9 88 0.04∗
Lynch syndrome 23.2 23 11.1 11
Education
Primary school 3.0 3 2.0 2 0.76
Secondary school 19.2 19 23.2 23
Low vocational education 10.1 10 13.1 13
Middle vocational training 38.4 38 38.4 38
Higher vocational education 19.2 19 18.2 18
University education 10.1 10 5.1 5
Dependent variables mean (SD) n mean (SD) n P
PPCa 1.41 (0.38) 95 1.41 (0.41) 94 0.90
Knowledgea 5.87 (2.39) 89 6.27 (2.40) 88 0.26
Risk perceptiona 33.51 (7.41) 93 32.96 (6.91) 89 0.61
Decision makinga
- Carrying out controls 4.81 (0.46) 97 4.90 (0.34) 98 0.15
- Doing a DNA test 4.82 (0.46) 97 4.84 (0.57) 99 0.85
- Preventive operation 3.45 (1.16) 97 3.40 (1.22) 98 0.74
- Informing family members 4.77 (0.55) 97 4.75 (0.63) 99 0.76
CWSa 0.28 (0.64) 97 0.33 (0.67) 99 0.56
GHQa 1.28 (2.35) 98 1.38 (2.58) 98 0.77
PPC, perceived personal control; GHQ, general health questionnaire; CWS, cancer worry scale.
aThese variables have missing values.
bMean and SD are shown instead of a percentage.
∗p ≤ 0.05.
risk perception or psychological functioning (Table 3).
There was no difference in personal control directly
after DNA test disclosure (T2), but at follow-up (T3)
counselees in the traditional group felt they had more
control on their life than counselees in the choice group.
The effect size was small to average (F(1, 126) =
6.62, p < 0.05, r = 0.22). To explain this unexpected
result, we looked at the influence of disclosure type
(by letter or face-to-face) and at the result (favourable
or unfavourable) on personal control in the choice
group at follow-up. However, the feeling of control
did not depend on how the result was disclosed in
the choice group (M = 1.35, SD = 0.49 vs M = 1.50,
SD = 0.56, t (67) = −1.11, p = n.s), nor on the test
result (favourable or unfavourable) (M = 1.43, SD =
0.48 vs M = 1.60, SD = 0.39, F(1, 126) = 3.61,
p = n.s).
Patient satisfaction
Satisfaction scores were generally very high. The scores
were always higher in the choice group, especially
at T3, but only reached significance in the general
satisfaction with the genetic counselling process at
follow-up (Table 3). The effect size was small to
average (M = 8.02, SD = 1.13 vs M = 8.59, SD =
0.97, F(1, 130) = 4.62, p < .05, r = 0.18). In Table 4,
the results for satisfaction are given for each group,
and are split up for both favourable and unfavourable
results. There were three significant interaction effects.
The satisfaction with the general genetic counselling
process shortly after result disclosure (T2) did not differ
between the traditional group and the choice group,
regardless of the test result. However, at follow-up (T3)
there was a significant difference in overall satisfaction
425
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Table 3. Overview of the dependent variables shortly after learning the result of the DNA test (T2) and 4–6 weeks later (T3)
Traditional protocol (N = 82) Choice protocol (N = 83)
Mean (SD) n Mean (SD) n p
Dependent variables
PPC (T2) 1.46 (0.57) 70 1.47 (0.40) 68 0.74
PPC (T3) 1.60 (0.38) 58 1.40 (0.50) 72 0.01∗
Knowledge (T2) 7.34 (2.17) 65 7.80 (2.00) 71 0.21
Knowledge (T3) 7.24 (2.09) 54 7.81 (2.15) 72 0.08
Risk perception (T2) 32.45 (7.54) 69 31.17 (7.90) 71 0.68
Risk perception (T3) 32.87 (7.14) 62 32.13 (7.68) 71 0.75
Decision-making (T2)
- Carrying out controls 4.74 (0.73) 73 4.87 (0.37) 78 0.34
- Doing a DNA test 4.92 (0.33) 72 4.92 (0.39) 77 0.97
- Preventive operation 3.73 (1.21) 73 3.81 (1.12) 78 0.99
- Informing family members 4.85 (0.36) 73 4.90 (0.38) 78 0.51
Decision-making (T3)
- Carrying out controls 4.78 (0.68) 63 4.95 (0.27) 78 0.13
- Doing a DNA test 4.98 (0.13) 63 4.94 (0.37) 78 0.52
- Preventive operation 3.86 (1.12) 63 3.77 (1.16) 78 0.30
- Informing family members 4.86 (0.44) 63 4.83 (0.57) 78 0.62
GHQ (T2) 1.74 (2.69) 72 2.28 (3.29) 78 0.09
GHQ (T3) 1.59 (2.89) 63 0.99 (2.31) 78 0.54
CWS (T2) 0.49 (0.82) 73 0.49 (0.79) 78 0.72
CWS (T3) 0.39 (0.75) 62 0.33 (0.70) 78 0.97
Satisfaction in general (T2) 8.34 (1.20) 65 8.65 (1.08) 68 0.32
Satisfaction in general (T3) 8.02 (1.13) 60 8.59 (0.97) 74 0.03∗
Satisfaction result procedure (T2) 8.39 (1.40) 71 8.74 (1.16) 76 0.44
Satisfaction result procedure (T3) 8.12 (1.29) 61 8.70 (1.02) 76 0.06
PPC, perceived personal control; GHQ, general health questionnaire; CWS, cancer worry scale.
∗p ≤ 0.05.
Table 4. Overview of the satisfaction results at T2 and T3
Traditional group Choice group
Unfavourable result Favourable result Unfavourable result Favourable result Interaction effect
Dependent variables Average SD n Average SD n Average SD n Average SD n p
Satisfaction in general (T2) 8.38 1.09 23 8.32 1.27 42 8.31 1.02 21 8.80 1.08 47 0.19
Satisfaction in general (T3) 8.19 1.04 21 7.92 1.18 39 8.16 0.72 22 8.77 1.01 52 0.02∗
Satisfaction about
disclosure (T2)
8.20 1.66 25 8.49 1.24 46 7.90 1.34 24 9.13 0.83 52 0.03∗
Satisfaction about
disclosure (T3)
8.21 1.33 21 8.08 1.28 40 8.09 1.26 23 8.97 0.77 53 0.01∗
∗p ≤ 0.05.
(F (1, 130) = 5.34, p < 0.05, r = 0.20), with a good
DNA result being the decisive factor. Regarding the
satisfaction with the disclosure procedure, there was
a significant difference at T2 (F(1, 143) = 4.87, p <
0.05, r = 0.18) and at T3 (F(1, 133) = 6.24, p < 0.05,
r = 0.21) between the counselees in the traditional
group and the choice group, again correlated to the
result. The effect sizes were small to average.
The interaction diagrams (Figure 2) show that coun-
selees with a favourable result in the choice group were
more satisfied with the disclosure procedure than all the
other counselees. This difference is clear both at T2 and
at T3. A similar pattern can be seen in general satis-
faction with the overall genetic counselling procedure.
Counselees with a favourable result in the choice group
were more satisfied with the predictive DNA testing
procedure than all the other counselees. This differ-
ence was not significant directly after the result was
disclosed, but at follow-up it was (Table 4).
The choice of disclosure procedure and subsequent
appointments
In the choice protocol group, at the end of the intake
session the counselee was informed about both options
in a standard way after which she/he had to choose how
to have the DNA test result disclosed. Of the 83 coun-
selees in the choice group, 26 (31%) wanted to hear
426
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Fig. 2. Interaction diagrams of general and disclosure satisfaction.
their result from the genetics counsellor in a face-to-face
consultation, while 57 (69%) chose to receive their
result by letter. There were no significant differences
on dependent and demographical variables between the
counselees who chose for a disclosure face-to-face and
the counselees who chose for a disclosure by letter.
Of those who received the result by letter, 18 (32%)
appeared to be mutation carriers and 39 (68%) had
a favourable DNA result. All the counselees who
appeared to have the mutation came to the subsequent
consultation with the counsellor to discuss the result
extensively. All but one of the counselees in whom the
familial mutation had been excluded (n = 38) cancelled
the face-to-face appointment. The one counselee who
kept his appointment did so because of an unrelated
familial disorder for which he wanted additional genetic
counselling.
Discussion
Nearly, 70% of the counselees who were offered a
choice, opted to receive their test result by letter, which
reflects a substantial preference for this procedure on
the part of counselees. Our study shows that by using
a choice protocol in which result disclosure by letter is
combined with the offer of a face-to-face contact within
several days, there is no indication of excess psycholog-
ical harm or loss of counselling quality. Compared to
the traditional procedure, patient satisfaction was gen-
erally higher when patients were offered a choice with
respect to how the test result was disclosed. In addition,
it turned out that nearly all the counselees who had cho-
sen to have their result by letter, cancelled the planned
face-to-face consultation if their result was favourable
(i.e. no mutation found), thereby reducing the genetic
counsellor’s work load.
One of our assumptions was that satisfaction with
the disclosure procedure would be higher in the choice
protocol than in the traditional protocol, and that there
would be no differences in the other quality aspects
of the genetic counselling. Indeed, our results in both
protocols showed minimal differences in all the quality
aspects. As for satisfaction, we could identify only one
main effect: at follow-up (T3), satisfaction with the
whole counselling procedure was higher in the choice
protocol group. However, it may be that the generally
very high satisfaction scores created a ‘ceiling effect’
which impedes detection of significant differences.
We assumed that satisfaction with the disclo-
sure procedure would be lowest for those with
427
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a favourable result and a mandatory face-to-face
disclosure according to the traditional protocol. This
effect was not found. However, the effect that we did
find is very similar: counselees in the choice protocol
group and with a favourable result were more satisfied
with the disclosure procedure than those in all the other
groups.
To our knowledge, this is the first study that explores
the use of a letter for disclosing a DNA test result.
However, as described in the introduction, some studies
have been carried out on disclosure by telephone with
counselees having a BRCA1/2 mutation risk (12–14).
Disclosure by phone has the advantage that the coun-
selee’s reaction can be assessed in real time and the
consequences of the test result can be discussed directly.
However, based on our experience in counselling prac-
tice, there are some disadvantages as well. It can be dif-
ficult to reach people during working hours and to speak
with them in a private and tranquil setting, even when
the day and time of telephone disclosure are planned
on forehand. A telephone conversation is also restricted
to one counsellor and one counselee, significant others
can rarely take part in the conversation at the moment
of disclosure. In contrast, a letter can be opened by the
counselee at a suitable moment and place; the test result
can be formulated unequivocally, and the planned next
appointment to discuss the test result is immediately
available. However, the validity of these assumptions
needs to be investigated by comparing the three ways
of disclosure: by phone, letter or face-to-face.
One unexpected finding was that, at follow-up (T3),
counselees in the traditional protocol group perceived
more personal control than counselees in the choice
group. Since neither the test result (favourable or
unfavourable) nor the disclosure format (letter or face-
to face) had influence on the PPC in the choice protocol
group, and the effect was not present at T2, but only
at follow-up, this might be a chance finding. It seems
unlikely, that the introduction of an extra choice into
the counselling procedure for pre-symptomatic DNA
testing in hereditary cancer would lead to a feeling
of less control, although it is possible that an extra
choice moment generated additional stress. However,
the counselees in the choice and traditional protocol
groups did not differ in the GHQ measurement, showing
that the stress level was equal between the groups.
A limitation of our study was that only 47.7% of
all the participants approached returned two or three
questionnaires. However, the fact that the drop-outs did
not differ in demographic and dependent variables from
the participants, makes it probably that our results can
be generalised to the whole BRCA1/2 population, pre-
suming that for men the procedure is relatively less
intrusive then for women as they will not be confronted
with preventive operation issues. Because the number
of counselees with a risk of Lynch syndrome was small,
generalization for this group cannot be made, although
earlier studies show that the psychological impact of
the counselling procedure is less for this population
compared to the BRCA1/2 population (8). A second
limitation is that the effect sizes of the significant results
were small to average. This is most probably because of
the fact that the current, careful, counselling procedure
already leads to a very high satisfaction amongst coun-
selees. Changes, such as the introduction of a choice in
the disclosure procedure can thus increase the satisfac-
tion score only a little (‘ceiling effect’). Nevertheless,
to offer the choice of disclosure by letter will not only
increase patient satisfaction but also enhance efficiency
and use of time for both the counselee and the genetics
counsellor. This was also obvious from the fact that
97.4% of the counselees with a favourable result dis-
closed by letter did not need a subsequent face-to-face
meeting. This led to a significant reduction in the time
needed for consultation, for both counsellor and coun-
selee. The advantage for the latter are even bigger when
geographical distances are large.
A point of attention is that our counselees came from
families where the causative gene mutation had already
been identified. Thus, no counselees with an ‘unclear
test result’, ‘uninformative test result’ or ‘variant type of
result’ were included in our study, which means that this
aspect of DNA testing could not be addressed. These
counselees could experience more stress than those who
get an unambiguous test result (8, 22). In addition,
we did not include patients with a personal history of
cancer or those with psychological/psychiatric problems
in our study. Whether our results are applicable to
these counselees needs to be investigated further.
Long-term effects should still be investigated, although
earlier research showed that the psychological impact
of counselling over time does not increase and is
related to pre-test distress (11, 23). Although our study
shows little need for consultation after a favourable
result in our study group, we emphasise this option
should always be given as sometimes counselees with
a favourable result suffer adverse psychological effects
such as survivor guilt (24).
In this study, we only investigated the disclosure
procedure to counselees with a risk of Lynch syndrome
or a BRCA1/2 mutation. Although there are many
forms of hereditary cancer, these are the most prevalent.
It seems unlikely that other ‘adult onset’ hereditary
cancer syndromes will require a different approach. In
hereditary cancer syndromes where children are tested
for mutations, e.g. FAP or MEN2A, a complicating
factor is that the result has to be given to the child
and the parents. However, here too we assume that
‘disclosure at home’ might be preferred by many
parents and children to a visit to the outpatient clinic.
Further study for this group is recommended.
In conclusion, we show in a large dataset that
offering a choice how to receive a pre-symptomatic
DNA result, either face-to-face or by letter with an
optional face-to-face consultation afterwards, improves
patient satisfaction, does not impede the quality of the
counselling procedure, nor the psychological well-being
of the counselees. Moreover, it improves counselling
efficiency for both counselee and counsellor. Our
findings may have important implications for the field
of pre-symptomatic testing for adult-onset disorders
in clinical genetics. Instead of following an identical
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approach for everyone, it could be considered to
assess the risk population which requires additional
psychosocial support. The normal population who, most
of the time, experience no serious psychological impact
of the DNA test, could be offered a choice to receive
the result face-to-face or by letter.
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